Breaking News Instant updates and real-time market news.

CLSD

Clearside Biomedical

$12.15

0.05 (0.41%)

06:16
05/17/18
05/17
06:16
05/17/18
06:16

Clearside Biomedical management to meet with JMP Securities

Meeting to be held in New York on May 17 hosted by JMP Securities.

  • 17

    May

  • 21

    May

  • 23

    May

CLSD Clearside Biomedical
$12.15

0.05 (0.41%)

01/30/18
JPMS
01/30/18
NO CHANGE
Target $15
JPMS
Overweight
Clearside Biomedical could rally 150% on positive study, says JPMorgan
JPMorgan analyst Anupam Rama believes Clearside Biomedical shares could rally 70%-150% on positive a Peachtree study versus down 50%-70% on negative data. Top-line data from the Phase 3 trial of Clearside's suprachoroidal CLS-TA in non-infectious uveitis is expected in Q1, likely in the late-February / early-March timeframe, Rama tells investors in a research note. He believes the Phase 2 Dogwood data are overall de-risking and that Clearside's adjustments going from Phase 2 to Phase 3 increases the probability of success for CLS-TA to 75%. The analyst lowered his price target for Clearside Biomedical shares to $15 from $17 and keeps an Overweight rating on the name.
03/05/18
JMPS
03/05/18
NO CHANGE
Target $25
JMPS
Outperform
Clearside Biomedical price target raised to $25 from $21 at JMP Securities
JMP Securities analyst Donald Ellis increased his estimate of the probability of approval for CLS-TA to 80% from 70% after the treatment demonstrated statistically significant efficacy on both primary and secondary endpoints, as well as a "highly clinically relevant" 15-letter improvement from baseline, in a Phase 3 trial in non-infectious uveitis patients. He maintains an Outperform rating on the stock and raised his price target to $25 to reflect his view of the increased odds of success after the data.
03/06/18
NEED
03/06/18
NO CHANGE
Target $22
NEED
Buy
Clearside Biomedical price target raised to $22 from $18 at Needham
Needham analyst Serge Belanger raised his price target on Clearside Biomedical to $22 after the company's "CLS-TA met the primary endpoint and all key secondary endpoints in the phase 3 PEACHTREE trial. The analyst also keeps his Buy rating, adding that the positive dataset allows Clearside Biomedical to proceed with an NDA filing for a uveitis indication in Q4 of this year while de-risking the overall program going into related data readouts later this year.
05/11/18
WEDB
05/11/18
NO CHANGE
WEDB
Clearside valuation attractive ahead of potential catalysts, says Wedbush
Wedbush analyst Liana Moussatos maintained an Outperform rating and $29 price target on Clearside Biomedical shares, saying the current valuation is attractive in front of multiple potential catalysts, including the Phase 2 TYBEE data for suprachoroidal CLS-TA in DME in Q2, preliminary data from the Phase 3 SAPPHIRE trial for MERVO in Q4, and NDA submission for ME-NIU to the FDA in Q4.

TODAY'S FREE FLY STORIES

CJ

C&J Energy Services

$28.78

-0.8 (-2.70%)

07:07
05/25/18
05/25
07:07
05/25/18
07:07
Initiation
C&J Energy Services initiated  »

C&J Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SVRA

Savara

$8.55

0.02 (0.23%)

07:06
05/25/18
05/25
07:06
05/25/18
07:06
Initiation
Savara initiated  »

Savara initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

07:05
05/25/18
05/25
07:05
05/25/18
07:05
General news
FX Update: The dollar has been trading mixed »

FX Update: The dollar has…

AZN

AstraZeneca

$36.88

0.035 (0.09%)

07:04
05/25/18
05/25
07:04
05/25/18
07:04
Hot Stocks
AstraZeneca announces PACIFIC trial meets overall survival endpoint »

AstraZeneca and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

MANT

ManTech

07:03
05/25/18
05/25
07:03
05/25/18
07:03
Initiation
ManTech initiated  »

ManTech initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACBFF

Aurora Cannabis

$0.00

(0.00%)

07:03
05/25/18
05/25
07:03
05/25/18
07:03
Hot Stocks
Aurora Cannabis retains KCSA for U.S. investor relations efforts »

Aurora Cannabis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$116.35

-0.2 (-0.17%)

07:03
05/25/18
05/25
07:03
05/25/18
07:03
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

SPX

S&P 500

$0.00

(0.00%)

07:02
05/25/18
05/25
07:02
05/25/18
07:02
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$82.95

0.35 (0.42%)

07:02
05/25/18
05/25
07:02
05/25/18
07:02
Recommendations
Ross Stores analyst commentary  »

Ross Stores weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$22.64

0.28 (1.25%)

07:02
05/25/18
05/25
07:02
05/25/18
07:02
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$81.55

0.48 (0.59%)

, EBAY

eBay

$37.79

-0.25 (-0.66%)

07:02
05/25/18
05/25
07:02
05/25/18
07:02
Recommendations
PayPal, eBay analyst commentary  »

PayPal price target…

PYPL

PayPal

$81.55

0.48 (0.59%)

EBAY

eBay

$37.79

-0.25 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 12

    Jun

GLD

SPDR Gold Trust

$123.61

1.07 (0.87%)

07:01
05/25/18
05/25
07:01
05/25/18
07:01
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGL

Engility

$30.17

0.33 (1.11%)

07:01
05/25/18
05/25
07:01
05/25/18
07:01
Initiation
Engility initiated  »

Engility initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$26.22

1.04 (4.13%)

07:01
05/25/18
05/25
07:01
05/25/18
07:01
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$14.87

0.54 (3.77%)

07:00
05/25/18
05/25
07:00
05/25/18
07:00
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$23.22

-0.99 (-4.09%)

07:00
05/25/18
05/25
07:00
05/25/18
07:00
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$47.36

-1.79 (-3.64%)

06:59
05/25/18
05/25
06:59
05/25/18
06:59
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$185.96

-0.94 (-0.50%)

06:59
05/25/18
05/25
06:59
05/25/18
06:59
Periodicals
Zuckerberg says 'vast majority' of users opt into invasive features, BI reports »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

VXX

iPath S&P 500 VIX Short-Term Futures

$33.82

-0.18 (-0.53%)

06:59
05/25/18
05/25
06:59
05/25/18
06:59
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNI

Canadian National

$83.75

-0.4 (-0.48%)

06:58
05/25/18
05/25
06:58
05/25/18
06:58
Upgrade
Canadian National rating change  »

Deutsche upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

ARLP

Alliance Resource Partners

$18.25

-0.45 (-2.41%)

06:58
05/25/18
05/25
06:58
05/25/18
06:58
Conference/Events
Alliance Resource Partners management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SPLK

Splunk

$116.35

-0.2 (-0.17%)

06:58
05/25/18
05/25
06:58
05/25/18
06:58
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$4.74

-0.02 (-0.42%)

06:58
05/25/18
05/25
06:58
05/25/18
06:58
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$13.59

0.03 (0.22%)

06:58
05/25/18
05/25
06:58
05/25/18
06:58
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$14.29

-0.225 (-1.55%)

06:57
05/25/18
05/25
06:57
05/25/18
06:57
Technical Analysis
United States Oil Fund: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.